Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Completed 3Unknown 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 3

Conditions

Breast Neoplasms 3Wound Infection 2Infections 2Surgical Wound Infection 1Laryngeal Neoplasms 1Bone Neoplasms 1

Interventions

Trastuzumab 350Paclitaxel 334Cyclophosphamide 315Docetaxel 291Capecitabine 181Doxorubicin 180Letrozole 166Tamoxifen 145Bevacizumab 124Fulvestrant 118Carboplatin 118exemestane 111Lapatinib 111Anastrozole 111Radiotherapy 105Epirubicin 104Gemcitabine 97palbociclib 84Exercise 78Vinorelbine 77Fluorouracil 77Surveys and Questionnaires 71pertuzumab 67Filgrastim 64Albumin-Bound Paclitaxel 64eribulin 55Magnetic Resonance Spectroscopy 55Everolimus 52Blood Specimen Collection 51Zoledronic Acid 50

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Breast Neoplasms × Cefazolin × Clear all
NCT02395614 2022-01-26

Surgical Site Infection With 0.05% Chlorhexidine (CHG) Compared to Triple Antibiotic Irrigation

Vanderbilt University Medical Center

Phase NA Completed
88 enrolled 10 charts
Breast

Breast Neoplasms

NCT04818931 2021-03-29

Does a Preoperative Prophylactic Antibiotic Reduce Surgical Site Infection Following Wire-localized Lumpectomy

CHU de Quebec-Universite Laval

Phase NA Completed
326 enrolled
Breast

Breast Neoplasms

NCT02809729 2017-10-25

Antibiotic Prophylaxis in Oncological Surgery of Breast

Universidade do Vale do Sapucai

Phase NA Completed
124 enrolled
Breast

Breast Neoplasms, Wound Infection

Data powered by HemOnc (CC BY 4.0) Colophon âš¡